
Life sciences job openings · Updated 2026-08-15
Emerging Data with FT819: Favorable Tolerability and Clinical Activity in Systemic Sclerosis Using Off-the-Shelf, iPSC-Derived Anti-CD19 CAR T cells without Fludarabine
The post Emerging Data with FT819: Favorable Tolerability and Clinical Activity in Systemic Sclerosis Using Off-the-Shelf, iPSC-Derived Anti-CD19 CAR T cells without Fludarabine appeared first on Fate Therapeutics .
Wallace Rheumatic Center
The post Wallace Rheumatic Center appeared first on Fate Therapeutics .
University of Louisville
The post University of Louisville appeared first on Fate Therapeutics .
Nicklaus Children’s Hospital
The post Nicklaus Children’s Hospital appeared first on Fate Therapeutics .
University of Florida
The post University of Florida appeared first on Fate Therapeutics .
FT839: A Multi-Antigen Targeting Off-the-Shelf Dual-CAR T Cell for the Treatment of Pathogenic B and T Cells in Autoimmune Diseases
The post FT839: A Multi-Antigen Targeting Off-the-Shelf Dual-CAR T Cell for the Treatment of Pathogenic B and T Cells in Autoimmune Diseases appeared first on Fate Therapeutics .
From official company newsrooms and press releases.
Company description, mission, culture, and benefits — visible after this page is claimed and verified.
Sign up free to search all 5 openings with AI-powered matching.
Search Fate Therapeutics JobsProfile generated from publicly available hiring data.
·Are you Fate Therapeutics? Claim this page or contact us